Abnormal Uterine Bleeding in Pre-Menopausal Women
Abstract Background Abnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of women will seek medical assistance for this problem during their reproductive years. This guideline replaces previous clinical guideli...
Saved in:
Published in | Journal of obstetrics and gynaecology Canada Vol. 35; no. 5; pp. 473 - 475 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English French |
Published |
Netherlands
Elsevier Inc
01.05.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Background Abnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of women will seek medical assistance for this problem during their reproductive years. This guideline replaces previous clinical guidelines on the topic and is aimed to enable health care providers with the tools to provide the latest evidence-based care in the diagnosis and the medical and surgical management of this common problem. Objective To provide current evidence-based guidelines for the diagnosis and management of abnormal uterine bleeding (AUB) among women of reproductive age. Outcomes Outcomes evaluated include the impact of AUB on quality of life and the results of interventions including medical and surgical management of AUB. Methods Members of the guideline committee were selected on the basis of individual expertise to represent a range of practical and academic experience in terms of location in Canada, type of practice, subspecialty expertise, and general gynaecology background. The committee reviewed relevant evidence in the English medical literature including published guidelines. Recommendations were established as consensus statements. The final document was reviewed and approved by the Executive and Council of the SOGC. Results This document provides a summary of up-to-date evidence regarding diagnosis, investigations, and medical and surgical management of AUB. The resulting recommendations may be adapted by individual health care workers when serving women with this condition. Conclusions Abnormal uterine bleeding is a common and sometimes debilitating condition in women of reproductive age. Standardization of related terminology, a systematic approach to diagnosis and investigation, and a step-wise approach to intervention is necessary. Treatment commencing with medical therapeutic modalities followed by the least invasive surgical modalities achieving results satisfactory to the patient is the ultimate goal of all therapeutic interventions. Evidence Published literature was retrieved through searches of MEDLINE and the Cochrane Library in March 2011 using appropriate controlled vocabulary (e.g. uterine hemorrhage, menorrhagia) and key words (e.g. menorrhagia, heavy menstrual bleeding, abnormal uterine bleeding). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies written in English and published from January 1999 to March 2011. Searches were updated on a regular basis and incorporated in the guideline to February 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. Values The quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table). Benefits, harms, and costs Implementation of the guideline recommendations will improve the health and well-being of women with abnormal uterine bleeding, their families, and society. The economic cost of implementing these guidelines in the Canadian health care system was not considered. |
---|---|
AbstractList | Abstract Background Abnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of women will seek medical assistance for this problem during their reproductive years. This guideline replaces previous clinical guidelines on the topic and is aimed to enable health care providers with the tools to provide the latest evidence-based care in the diagnosis and the medical and surgical management of this common problem. Objective To provide current evidence-based guidelines for the diagnosis and management of abnormal uterine bleeding (AUB) among women of reproductive age. Outcomes Outcomes evaluated include the impact of AUB on quality of life and the results of interventions including medical and surgical management of AUB. Methods Members of the guideline committee were selected on the basis of individual expertise to represent a range of practical and academic experience in terms of location in Canada, type of practice, subspecialty expertise, and general gynaecology background. The committee reviewed relevant evidence in the English medical literature including published guidelines. Recommendations were established as consensus statements. The final document was reviewed and approved by the Executive and Council of the SOGC. Results This document provides a summary of up-to-date evidence regarding diagnosis, investigations, and medical and surgical management of AUB. The resulting recommendations may be adapted by individual health care workers when serving women with this condition. Conclusions Abnormal uterine bleeding is a common and sometimes debilitating condition in women of reproductive age. Standardization of related terminology, a systematic approach to diagnosis and investigation, and a step-wise approach to intervention is necessary. Treatment commencing with medical therapeutic modalities followed by the least invasive surgical modalities achieving results satisfactory to the patient is the ultimate goal of all therapeutic interventions. Evidence Published literature was retrieved through searches of MEDLINE and the Cochrane Library in March 2011 using appropriate controlled vocabulary (e.g. uterine hemorrhage, menorrhagia) and key words (e.g. menorrhagia, heavy menstrual bleeding, abnormal uterine bleeding). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies written in English and published from January 1999 to March 2011. Searches were updated on a regular basis and incorporated in the guideline to February 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. Values The quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table). Benefits, harms, and costs Implementation of the guideline recommendations will improve the health and well-being of women with abnormal uterine bleeding, their families, and society. The economic cost of implementing these guidelines in the Canadian health care system was not considered. Abnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of women will seek medical assistance for this problem during their reproductive years. This guideline replaces previous clinical guidelines on the topic and is aimed to enable health care providers with the tools to provide the latest evidence-based care in the diagnosis and the medical and surgical management of this common problem. To provide current evidence-based guidelines for the diagnosis and management of abnormal uterine bleeding (AUB) among women of reproductive age. Outcomes evaluated include the impact of AUB on quality of life and the results of interventions including medical and surgical management of AUB. Members of the guideline committee were selected on the basis of individual expertise to represent a range of practical and academic experience in terms of location in Canada, type of practice, subspecialty expertise, and general gynaecology background. The committee reviewed relevant evidence in the English medical literature including published guidelines. Recommendations were established as consensus statements. The final document was reviewed and approved by the Executive and Council of the SOGC. This document provides a summary of up-to-date evidence regarding diagnosis, investigations, and medical and surgical management of AUB. The resulting recommendations may be adapted by individual health care workers when serving women with this condition. Abnormal uterine bleeding is a common and sometimes debilitating condition in women of reproductive age. Standardization of related terminology, a systematic approach to diagnosis and investigation, and a step-wise approach to intervention is necessary. Treatment commencing with medical therapeutic modalities followed by the least invasive surgical modalities achieving results satisfactory to the patient is the ultimate goal of all therapeutic interventions. Published literature was retrieved through searches of MEDLINE and the Cochrane Library in March 2011 using appropriate controlled vocabulary (e.g. uterine hemorrhage, menorrhagia) and key words (e.g. menorrhagia, heavy menstrual bleeding, abnormal uterine bleeding). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies written in English and published from January 1999 to March 2011. Searches were updated on a regular basis and incorporated in the guideline to February 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. The quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table). Implementation of the guideline recommendations will improve the health and well-being of women with abnormal uterine bleeding, their families, and society. The economic cost of implementing these guidelines in the Canadian health care system was not considered. Abnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of women will seek medical assistance for this problem during their reproductive years. This guideline replaces previous clinical guidelines on the topic and is aimed to enable health care providers with the tools to provide the latest evidence-based care in the diagnosis and the medical and surgical management of this common problem. To provide current evidence-based guidelines for the diagnosis and management of abnormal uterine bleeding (AUB) among women of reproductive age. Outcomes evaluated include the impact of AUB on quality of life and the results of interventions including medical and surgical management of AUB. Members of the guideline committee were selected on the basis of individual expertise to represent a range of practical and academic experience in terms of location in Canada, type of practice, subspecialty expertise, and general gynaecology background. The committee reviewed relevant evidence in the English medical literature including published guidelines. Recommendations were established as consensus statements. The final document was reviewed and approved by the Executive and Council of the SOGC. This document provides a summary of up-to-date evidence regarding diagnosis, investigations, and medical and surgical management of AUB. The resulting recommendations may be adapted by individual health care workers when serving women with this condition. Abnormal uterine bleeding is a common and sometimes debilitating condition in women of reproductive age. Standardization of related terminology, a systematic approach to diagnosis and investigation, and a step-wise approach to intervention is necessary. Treatment commencing with medical therapeutic modalities followed by the least invasive surgical modalities achieving results satisfactory to the patient is the ultimate goal of all therapeutic interventions. Published literature was retrieved through searches of MEDLINE and the Cochrane Library in March 2011 using appropriate controlled vocabulary (e.g. uterine hemorrhage, menorrhagia) and key words (e.g. menorrhagia, heavy menstrual bleeding, abnormal uterine bleeding). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies written in English and published from January 1999 to March 2011. Searches were updated on a regular basis and incorporated in the guideline to February 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. The quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table). Implementation of the guideline recommendations will improve the health and well-being of women with abnormal uterine bleeding, their families, and society. The economic cost of implementing these guidelines in the Canadian health care system was not considered. BACKGROUNDAbnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of women will seek medical assistance for this problem during their reproductive years. This guideline replaces previous clinical guidelines on the topic and is aimed to enable health care providers with the tools to provide the latest evidence-based care in the diagnosis and the medical and surgical management of this common problem.OBJECTIVETo provide current evidence-based guidelines for the diagnosis and management of abnormal uterine bleeding (AUB) among women of reproductive age.OUTCOMESOutcomes evaluated include the impact of AUB on quality of life and the results of interventions including medical and surgical management of AUB.METHODSMembers of the guideline committee were selected on the basis of individual expertise to represent a range of practical and academic experience in terms of location in Canada, type of practice, subspecialty expertise, and general gynaecology background. The committee reviewed relevant evidence in the English medical literature including published guidelines. Recommendations were established as consensus statements. The final document was reviewed and approved by the Executive and Council of the SOGC.RESULTSThis document provides a summary of up-to-date evidence regarding diagnosis, investigations, and medical and surgical management of AUB. The resulting recommendations may be adapted by individual health care workers when serving women with this condition.CONCLUSIONSAbnormal uterine bleeding is a common and sometimes debilitating condition in women of reproductive age. Standardization of related terminology, a systematic approach to diagnosis and investigation, and a step-wise approach to intervention is necessary. Treatment commencing with medical therapeutic modalities followed by the least invasive surgical modalities achieving results satisfactory to the patient is the ultimate goal of all therapeutic interventions.EVIDENCEPublished literature was retrieved through searches of MEDLINE and the Cochrane Library in March 2011 using appropriate controlled vocabulary (e.g. uterine hemorrhage, menorrhagia) and key words (e.g. menorrhagia, heavy menstrual bleeding, abnormal uterine bleeding). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies written in English and published from January 1999 to March 2011. Searches were updated on a regular basis and incorporated in the guideline to February 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies.VALUESThe quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table).BENEFITS, HARMS, AND COSTSImplementation of the guideline recommendations will improve the health and well-being of women with abnormal uterine bleeding, their families, and society. The economic cost of implementing these guidelines in the Canadian health care system was not considered. |
Author | Leyland, Nicholas, MD Dunn, Sheila, MD Best, Carolyn, MD Wolfman, Wendy Lynn, MD Singh, Sukhbir, MD |
Author_xml | – sequence: 1 fullname: Singh, Sukhbir, MD – sequence: 2 fullname: Best, Carolyn, MD – sequence: 3 fullname: Dunn, Sheila, MD – sequence: 4 fullname: Leyland, Nicholas, MD – sequence: 5 fullname: Wolfman, Wendy Lynn, MD |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23756279$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkD1PwzAQQD0UUQr8BFBHGAJ3cR03C6hUfEkgkKBitBznggyJXewGiX9P-gEDC5Ol07t38huwnvOOGDtAOEHA7PQJJWCSYsaPUBxzyHmeyB7b-R332SDGNwAhucy3WT_lUmSpzHcYTgrnQ6Pr4WxBwToaXtREpXWvQ-uGj4GSe3J-rtvYIS--IbfHtipdR9rfvLtsdnX5PL1J7h6ub6eTu8SMUlgkkqdQFlBVWOB4NAYD45RA6LwqCy7HWiM3KGAkNFaQmqzISiKU0phcZwYLvsuO1t558B8txYVqbDRU19qRb6NCnkkBGce8Q8UaNcHHGKhS82AbHb4UgloWUqtCaplCoVCrQkp2e4ebE23RUPm79ZOnA87XAHUf_bQUVDSWnOkCBTILVXr774mzPwZTW2eNrt_pi-Kbb4PrKipUMVWwliwdKFYGyb8Bu0iMkg |
CitedBy_id | crossref_primary_10_1111_jog_15226 crossref_primary_10_1097_AOG_0000000000001529 crossref_primary_10_1007_s40264_021_01072_0 crossref_primary_10_15591_mtp_2014_063 crossref_primary_10_5812_ircmj_60508 crossref_primary_10_16948_zktipb_292821 crossref_primary_10_1016_j_jogc_2020_06_012 crossref_primary_10_1016_j_ajog_2022_03_025 crossref_primary_10_1016_j_jogoh_2017_07_005 crossref_primary_10_1097_GCO_0000000000000609 crossref_primary_10_1016_j_medcli_2021_02_006 crossref_primary_10_1016_j_ajog_2017_12_206 crossref_primary_10_1016_j_medcle_2021_02_009 crossref_primary_10_1007_s13224_014_0641_1 crossref_primary_10_1016_j_jmig_2018_04_013 crossref_primary_10_1111_jog_15669 crossref_primary_10_1016_j_vph_2017_05_001 crossref_primary_10_1186_s13048_018_0420_1 crossref_primary_10_18370_2309_4117_2021_62_64_74 crossref_primary_10_28982_josam_7934 crossref_primary_10_9778_cmajo_20190170 crossref_primary_10_1016_j_jpag_2016_09_012 crossref_primary_10_17116_repro20212702156 crossref_primary_10_1016_j_jogc_2016_09_063 crossref_primary_10_1007_s00404_015_3868_x crossref_primary_10_1185_03007995_2014_982246 crossref_primary_10_1155_2019_8910374 crossref_primary_10_1371_journal_pone_0229123 crossref_primary_10_1166_sam_2023_4595 crossref_primary_10_21518_2079_701X_2022_16_5_32_39 crossref_primary_10_1111_bjh_18291 crossref_primary_10_1155_2019_8598152 crossref_primary_10_1016_S1701_2163_15_30338_8 crossref_primary_10_1097_AOG_0000000000001031 crossref_primary_10_1016_j_jogc_2016_09_067 crossref_primary_10_14442_generalist_36_237 crossref_primary_10_1016_j_jogc_2018_10_002 crossref_primary_10_1080_13625187_2021_1925881 crossref_primary_10_1016_j_jpag_2014_12_012 crossref_primary_10_3390_diagnostics10110884 crossref_primary_10_1016_j_ajog_2016_06_006 crossref_primary_10_1007_s13224_016_0925_8 crossref_primary_10_1007_s11239_024_03006_w crossref_primary_10_1016_j_bpobgyn_2016_09_009 crossref_primary_10_1016_j_jogc_2015_11_005 crossref_primary_10_5005_jp_journals_10032_1117 crossref_primary_10_4103_amhs_amhs_60_23 crossref_primary_10_1007_s00129_022_05022_4 crossref_primary_10_1016_j_jogc_2019_02_002 crossref_primary_10_1016_j_ygyno_2023_05_061 crossref_primary_10_1089_jwh_2016_6155 crossref_primary_10_17116_onkolog2020906134 crossref_primary_10_17116_rosakush201818462 crossref_primary_10_1016_j_jogc_2018_12_006 crossref_primary_10_1016_j_jogc_2018_12_007 crossref_primary_10_4103_jfmpc_jfmpc_514_20 crossref_primary_10_1080_13645706_2021_1910312 crossref_primary_10_1093_humupd_dmz051 crossref_primary_10_1016_j_jogc_2022_07_002 crossref_primary_10_1080_13645706_2018_1467459 crossref_primary_10_7863_ultra_15_12017 crossref_primary_10_1007_s00404_016_4043_8 crossref_primary_10_1016_j_bpobgyn_2017_01_001 crossref_primary_10_18370_2309_4117_2019_47_8_12 crossref_primary_10_1016_j_jogc_2018_11_017 crossref_primary_10_1016_j_jogc_2018_04_023 crossref_primary_10_7759_cureus_21839 crossref_primary_10_1016_j_jogc_2018_04_024 crossref_primary_10_1080_09513590_2017_1417376 crossref_primary_10_18410_jebmh_2020_222 crossref_primary_10_1016_j_jogc_2019_04_003 crossref_primary_10_1186_s12905_024_03047_6 crossref_primary_10_1371_journal_pone_0217579 crossref_primary_10_26442_2079_5696_2018_2_14_18 crossref_primary_10_1093_fampra_cmx050 crossref_primary_10_18229_kocatepetip_1105749 crossref_primary_10_4236_ojog_2017_75053 crossref_primary_10_4236_ojog_2017_73033 crossref_primary_10_1016_S1701_2163_15_30288_7 crossref_primary_10_1371_journal_pone_0226992 crossref_primary_10_1016_j_medre_2017_10_002 crossref_primary_10_1097_PGP_0000000000000569 crossref_primary_10_1007_s13224_017_1050_z crossref_primary_10_1016_j_jogc_2018_07_016 crossref_primary_10_1111_1471_0528_15388 |
ContentType | Journal Article |
Contributor | Dunn, Sheila Singh, Sukhbir Wolfman, Wendy Best, Carolyn Potestio, Frank Marcoux, Violaine Rittenberg, David Leyland, Nicholas Heywood, Mark Menard, Chantal Awadalla, Alaa Allaire, Catherine Lemyre, Madeleine |
Contributor_xml | – sequence: 1 givenname: Nicholas surname: Leyland fullname: Leyland, Nicholas organization: North York ON – sequence: 2 givenname: Wendy surname: Wolfman fullname: Wolfman, Wendy organization: Toronto ON – sequence: 3 givenname: Catherine surname: Allaire fullname: Allaire, Catherine organization: Vancouver BC – sequence: 4 givenname: Alaa surname: Awadalla fullname: Awadalla, Alaa organization: Winnipeg MB – sequence: 5 givenname: Carolyn surname: Best fullname: Best, Carolyn organization: Toronto ON – sequence: 6 givenname: Sheila surname: Dunn fullname: Dunn, Sheila organization: Toronto ON – sequence: 7 givenname: Mark surname: Heywood fullname: Heywood, Mark organization: Vancouver BC – sequence: 8 givenname: Madeleine surname: Lemyre fullname: Lemyre, Madeleine organization: Quebec QC – sequence: 9 givenname: Violaine surname: Marcoux fullname: Marcoux, Violaine organization: Ville Mont-Royal QC – sequence: 10 givenname: Chantal surname: Menard fullname: Menard, Chantal organization: Ottawa ON – sequence: 11 givenname: Frank surname: Potestio fullname: Potestio, Frank organization: Thunder Bay ON – sequence: 12 givenname: David surname: Rittenberg fullname: Rittenberg, David organization: Halifax NS – sequence: 13 givenname: Sukhbir surname: Singh fullname: Singh, Sukhbir organization: Ottawa ON |
Copyright | Society of Obstetricians and Gynaecologists of Canada 2013 Society of Obstetricians and Gynaecologists of Canada |
Copyright_xml | – notice: Society of Obstetricians and Gynaecologists of Canada – notice: 2013 Society of Obstetricians and Gynaecologists of Canada |
CorporateAuthor | CLINICAL PRACTICE – GYNAECOLOGY COMMITTEE |
CorporateAuthor_xml | – name: CLINICAL PRACTICE – GYNAECOLOGY COMMITTEE |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/S1701-2163(15)30939-7 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EndPage | 475 |
ExternalDocumentID | 10_1016_S1701_2163_15_30939_7 23756279 S1701216315309397 1_s2_0_S1701216315309397 |
Genre | Journal Article Practice Guideline |
GroupedDBID | 0R 1- 1P 457 AAIAV AALRI AAXUO ACGFS AEVXI AFRHN AFTJW AGHFR AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS EBS EJD F5P FDB FO GX1 O9- OK1 OQ. PH ROL SJN Z5R .1- .FO 0R~ 1P~ PH~ AFJKZ CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c420t-7320db0ff1b18480c082e05a9fdb378aa13c15045a1f02c6b6dee177cc9a6c1b3 |
ISSN | 1701-2163 |
IngestDate | Fri Aug 16 08:48:39 EDT 2024 Thu Sep 26 23:32:41 EDT 2024 Sat Sep 28 07:57:43 EDT 2024 Sat Apr 29 22:45:50 EDT 2023 Thu Aug 18 17:14:57 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | endometrial ablation heavy menstrual bleeding Menorrhagia abnormal uterine bleeding hysterectomy menorrhagia |
Language | English French |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c420t-7320db0ff1b18480c082e05a9fdb378aa13c15045a1f02c6b6dee177cc9a6c1b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Instructional Material/Guideline-2 ObjectType-Feature-3 content type line 23 |
PMID | 23756279 |
PQID | 1367506319 |
PQPubID | 23479 |
PageCount | 3 |
ParticipantIDs | proquest_miscellaneous_1367506319 crossref_primary_10_1016_S1701_2163_15_30939_7 pubmed_primary_23756279 elsevier_sciencedirect_doi_10_1016_S1701_2163_15_30939_7 elsevier_clinicalkeyesjournals_1_s2_0_S1701216315309397 |
PublicationCentury | 2000 |
PublicationDate | 2013-05-01 |
PublicationDateYYYYMMDD | 2013-05-01 |
PublicationDate_xml | – month: 05 year: 2013 text: 2013-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Journal of obstetrics and gynaecology Canada |
PublicationTitleAlternate | J Obstet Gynaecol Can |
PublicationYear | 2013 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
SSID | ssj0057379 |
Score | 2.283773 |
Snippet | Abstract Background Abnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to... Abnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of women will... BACKGROUNDAbnormal uterine bleeding is the direct cause of a significant health care burden for women, their families, and society as a whole. Up to 30% of... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 473 |
SubjectTerms | abnormal uterine bleeding endometrial ablation Female heavy menstrual bleeding Humans hysterectomy Menorrhagia Obstetrics and Gynecology Premenopause Uterine Hemorrhage - diagnosis Uterine Hemorrhage - therapy |
Title | Abnormal Uterine Bleeding in Pre-Menopausal Women |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S1701216315309397 https://dx.doi.org/10.1016/S1701-2163(15)30939-7 https://www.ncbi.nlm.nih.gov/pubmed/23756279 https://search.proquest.com/docview/1367506319 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbEJiFeEL8ZAxQkkEAow47juHkcaGNC3XhoK_XNsh2bVlTp1LQP3V_POXacTVAxeImiKGcrd5e775LzZ4TeWlZKm1uWVpTbNK9UmQKqxynDuYIEm5W6JXs-vyjOJvm3KZv2m3G2q0vW6khf_XFdyf9YFa6BXd0q2X-wbBwULsA52BeOYGE43srGx6p2kHPx0e3L4OCiWvhk1PaGr0zqqMAv5aaBW1qqhR1QdKnA1o6q3xM2_9jW0mhPztSyF8TQPYKxZ76Z5-dMzWNj72fT9O0j2-hvHToezcx8EQcZmm3XTgl-6GrrG98eyLVOvxAuOSZpRkKICvHU048Ev2HXgmPuNy0JeTb3O6b8FsL914RRHNrxVbF3gEpwScuU93mr-1d_8V2cToZDMT6Zju-g_YyXzFXhX6ex14dxT7oYx-yXcn3qJ3pP2IcwyS6QsqsIacHI-AG6H0yXHHuXeIj2TZ3Y1SN09zy0SjxGpHOOJDhH0jlHMq-Tm86RtM7xBE1OT8ZfztKwP0aq8wyvU04zXClsLVFQpw-wBjhnMJOlrRTlAykJ1YD3cyaJxZkuVFEZQzjXupSFJoo-RXv1sjbPUVJJyc2g0IYblWtjlbSWamklpUbarDxAR51CxKWnQRGxP9BpUDgNCsJEq0HBDxDv1Ca6Nb6QlUwTXp9GENFkAntpJwyp14mC5CBKBhTo0Z0AD_nbpG86AwmIku7Xl6zNcgOTUSiMAY0TeJJn3nLxOTLKoQjg5YtbSB-ie_178BLtrVcb8wpQ6Vq9bj3uF078iNo |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abnormal+uterine+bleeding+in+pre-menopausal+women&rft.jtitle=Journal+of+obstetrics+and+gynaecology+Canada&rft.au=Singh%2C+Sukhbir&rft.au=Best%2C+Carolyn&rft.au=Dunn%2C+Sheila&rft.au=Leyland%2C+Nicholas&rft.date=2013-05-01&rft.issn=1701-2163&rft.volume=35&rft.issue=5&rft.spage=473&rft.epage=475&rft_id=info:doi/10.1016%2FS1701-2163%2815%2930939-7&rft.externalDBID=NO_FULL_TEXT |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F17012163%2FS1701216313X52004%2Fcov150h.gif |